SCHEMBL7744056

SCHEMBL7744056

CCCCC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1C1=CC=CCC1=S

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
NPSR1 Q6W5P4 3/20 0.42
TSHR P16473 2/20 0.42
USP2 O75604 1/20 0.42
KDR P35968 2/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDM4E B2RXH2 10/20 0.40
ALDH1A1 P00352 8/20 0.40
HSD17B10 Q99714 6/20 0.40
ADORA1 P30542 2/20 0.39
MAPK1 P28482 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAPT P10636 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7744773 0.89 HPN (0.41) HPGDSMN1; SMN2NPSR1TSHRUSP2
SCHEMBL7744196 0.87 KDR (0.54) SMN1; SMN2TSHRKDRFLT1FLT4
SCHEMBL7744779 0.85 KDR (0.43) HPGDSMN1; SMN2TSHRKDRFLT1
SCHEMBL7739022 0.85 KDR (0.54) HPGDSMN1; SMN2NPSR1TSHRUSP2
SCHEMBL7744069 0.83 KDR (0.40) HPGDSMN1; SMN2NPSR1TSHRUSP2
SCHEMBL7979629 0.82 KDR (0.39) HPGDSMN1; SMN2TSHRKDRFLT1
SCHEMBL7744659 0.81 KDR (0.50) HPGDSMN1; SMN2NPSR1TSHRUSP2
SCHEMBL7980768 0.80 KDR (0.45) NPSR1KDRFLT1FLT4KDM4E
SCHEMBL7744041 0.80 HPGD (0.46) HPGDSMN1; SMN2NPSR1TSHRUSP2
SCHEMBL7744162 0.80 KDR (0.45) HPGDSMN1; SMN2NPSR1TSHRUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed